TY - JOUR
T1 - Stimulation of luteinizing hormone (LH) and follicle stimulating hormone by [D Leu6,des Gly10 NH2] LH releasing hormone ethylamide after subcutaneous, intravaginal, and intrarectal administration to women
AU - Saito, M.
AU - Kumasaki, T.
AU - Yaoi, Y.
AU - Nishi, N.
AU - Arimura, A.
AU - Coy, D. H.
AU - Schally, A. V.
PY - 1977/1/1
Y1 - 1977/1/1
N2 - Women, most of whom had regular menstrual cycles, were administered [D Leu 6, des Gly 10 NH 2] luteinizing hormone releasing hormone (LH RH) ethylamide (D Leu 6 LH RH EA) via different routes during the early or midfollicular phase of the cycle. Plasma LH, follicle stimulating hormone (FSH), and estrogen levels were determined by radioimmunoassay before and after administration of D Leu 6 LH RH EA. Plasma LH and FSH increased and reached peak levels 3 to 4 hr and 3 to 6 hr, respectively, after subcutaneous injection of 25 μg of the analog of LH RH. Intravaginal or intrarectal application of 2 mg of D Leu 6 LH RH EA also increased plasma LH and FSH levels in most of the women, but the magnitude of the rise, the time of initiation of response, and the peak level varied among the women. The plasma estrogen level also rose after administration via either route.
AB - Women, most of whom had regular menstrual cycles, were administered [D Leu 6, des Gly 10 NH 2] luteinizing hormone releasing hormone (LH RH) ethylamide (D Leu 6 LH RH EA) via different routes during the early or midfollicular phase of the cycle. Plasma LH, follicle stimulating hormone (FSH), and estrogen levels were determined by radioimmunoassay before and after administration of D Leu 6 LH RH EA. Plasma LH and FSH increased and reached peak levels 3 to 4 hr and 3 to 6 hr, respectively, after subcutaneous injection of 25 μg of the analog of LH RH. Intravaginal or intrarectal application of 2 mg of D Leu 6 LH RH EA also increased plasma LH and FSH levels in most of the women, but the magnitude of the rise, the time of initiation of response, and the peak level varied among the women. The plasma estrogen level also rose after administration via either route.
UR - http://www.scopus.com/inward/record.url?scp=0017332267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017332267&partnerID=8YFLogxK
U2 - 10.1016/S0015-0282(16)42432-5
DO - 10.1016/S0015-0282(16)42432-5
M3 - Article
C2 - 320053
AN - SCOPUS:0017332267
VL - 28
SP - 240
EP - 245
JO - Scientific Computing and Instrumentation
JF - Scientific Computing and Instrumentation
SN - 1078-8956
IS - 3
ER -